Uptake of antibody-opsonized cancer cells by APCs, such as macrophages and DCs may also lead to enhanced antigen presentation, which may contribute to the development of tumor antigen-specific CD4+ and CD8+ T-cell immune responses [46,47]. This evidence concerns the gene CD8A and neoplasm.